These trials showed clinically significant pharmacokinetic interactions [7] characterized by a lower from the clearance on the anticancer drug and hence elevated exposure. The interpretation of subsequent phase II and III medical trials was complicated as it was impossible to administer precisely the same dose of chemotherapy in the existence https://waynem766zju9.thebindingwiki.com/user